Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
pipeline
Biotech
Erasca lays off 18%, swaps out KRAS program for fresh options
Erasca is spending $22.5 million to import fresh KRAS and molecular glue assets while clearing space in its pipeline and laying off 18% of staff.
James Waldron
May 17, 2024 5:30am
Biogen walks away from Ionis-partnered ALS, Angelman prospects
May 16, 2024 9:24am
BioMarin sheds 170 jobs in wake of narrowed R&D refocus
May 15, 2024 7:13am
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
Pfizer plans to be 'very active' in obesity despite setbacks
May 1, 2024 1:42pm
Gilead gives up on $4.9B antibody magrolimab
Apr 26, 2024 10:04am